In a recent study published in Cytokine & Growth Factor Reviews, researchers discussed the development of messenger ribonucleic acid (mRNA) vaccines against the respiratory syncytial virus (RSV).
MELBOURNE, Australia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral ...
The global respiratory device market witnessed substantial growth, reaching USD 15.8 billion in 2020 and is projected to reach USD 38.0 billion by 2027, with a notable CAGR of 13.5% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback